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The Use of Magnetic Resonance Imaging
to Predict the Clinical Outcome of 
Non-Surgical Treatment for Lumbar
Interverterbal Disc Herniation
Objective: We wanted to investigate the relationship between the magnetic
resonance (MR) findings and the clinical outcome after treatment with non-surgi-
cal transforaminal epidural steroid injections (ESI) for lumbar herniated interverte-
bral disc (HIVD) patients. 
Materials and Methods: Transforaminal ESI were performed in 91 patients (50
males and 41 females, age range: 13 78 yrs) because of lumbosacral HIVD
from March 2001 to August 2002. Sixty eight patients whose MRIs and clinical
follow-ups were available were included in this study. The medical charts were
retrospectively reviewed and the patients were divided into two groups; the suc-
cessful (responders, n = 41) and unsatisfactory (non-responders, n = 27) out-
come groups. A successful outcome required a patient satisfaction score greater
than two and a pain reduction score greater than 50%. The MR findings were ret-
rospectively analyzed and compared between the two groups with regard to the
type (protrusion, extrusion or sequestration), hydration (the T2 signal intensity),
location (central, right/left central, subarticular, foraminal or extraforaminal), and
size (volume) of the HIVD, the grade of nerve root compression (grade 1 abut-
ment, 2 displacement and 3 entrapment), and an association with spinal stenosis. 
Results: There was no significant difference between the responders and non-
responders in terms of the type, hydration and size of the HIVD, or an association
with spinal stenosis (p > 0.05). However, the location of the HIVD and the grade
of nerve root compression were different between the two groups (p < 0.05).
Conclusion: MRI could play an important role in predicting the clinical outcome
of non-surgical transforaminal ESI treatment for patients with lumbar HIVD.
ntervertebral disc herniations are the most common cause of lumbosacral
radiculopathy, and 10 15% of patients with these herniations will
eventually require surgery (1, 2). Non-surgical care includes bed rest,
oral medication, lumbar corsets and physical therapy. Epidural steroid injections (ESI)
have historically been used as an adjunct in the treatment of sciatica, and the reported
success rates have varied from 20 100%, with an average of 67% (3, 4). This large
variation is the result of several methodological and technical differences of this
treatment (5). Among the various techniques, recent studies have indicated that
fluoroscopic-guided transforaminal ESI with contrast agent injection achieves high
success rates in the patients with lumbar disc herniations (6, 7). Nevertheless, the
symptoms persist in a significant number of patients and surgery is eventually
required. 
Many studies have tried to identify the clinical criteria that would predict which
patients are most likely to respond to non-surgical treatment (6 10). Others have
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Itried to determine the imaging criteria that would predict
which disc herniations are most likely to decrease in size in
response to non-surgical treatment (11 16). We
undertook a retrospective trial to investigate the relation-
ship between the magnetic resonance (MR) findings and




Between March 1, 2001 and August 25, 2002, a total of
263 patients were referred to the Department of
Diagnostic Radiology for image-guided percutaneous
steroid injections. 91 of 263 patients (50 males and 41
females, age range: 13 78 yrs) were treated with
transforaminal ESI for lumbosacral disc herniations. The
diagnosis and treatment of the patients was the result of a
consensus between an orthopedic surgeon and a
musculoskeletal radiologist after having considered the
patients’ history and the results of physical examinations,
plain radiographs, the computed tomography (CT) or MR
imaging findings and the electrodiagnostic studies. The ESI
indications were 1) a chief complaint primarily of leg pain
that did not respond to at least three weeks of conservative
treatment with oral medication and physical therapy,
except for four patients who needed hospital treatment
because of the severity of leg pain, 2) the history, physical
examination and pain being consistent with lumbar radicu-
lopathy, and 3) MRI/CT results documenting a herniated
lumbar disc with nerve root compression or contact at the
level and side of the clinical signs and symptoms. The
exclusion criteria were progressive neurological deficits,
recent epidural steroid injections, a blood coagulation
disorder and an allergic reaction to local anesthetics or
corticosteroids. The diagnosis of the patients whose MRI
documented small disc herniation with severe central
spinal stenosis was regarded as spinal stenosis rather than
disc herniation. 
Twenty-three of 91 patients whose imaging studies were
CT/oust side MRI (n = 13) or whose clinical follow-ups
after the injections were missed (n = 10) were excluded in
this analysis. A total 68 patients were included in this study
with an average follow-up period of 3.6 months (range: 7
days 24 months); 10 patients’ follow-up period was
within one month, 36 patients’ follow-up period was from
one to three months, four patients’ follow-up period was
up to six months and 11 patients’ follow-up period was
greater than six months. The patients visited our clinic
after the injection and they were routinely observed,
unless particular symptoms persisted. The outcome was
measured using a patient satisfaction scale with choice
options of 0 (poor), 1 (fair), 2 (good), 3 (very good) and 4
(excellent), and a visual numeric pain scale ranging from
one to 10 at every visit before and after the injection.
The patients were divided into two groups; the successful
(responders) and unsatisfactory (non-responders) outcome
groups. A successful outcome required a patient satisfac-
tion score greater than two and a pain reduction score
greater than 50% at the last visit. 41 of 68 patients
(60.3%) had successful outcomes, with an average follow-
up period of 4.2 months (range: 3 weeks 24 months).
These patients were comprised of 25 men and 16 women
with a mean age of 43 years (range: 19 78 years).
Twenty- seven patients showed unsatisfactory results, and
they had an average follow-up period of 2.7 months
(range: 7 days 22 months). These patients were
comprised of 12 men and 15 women with a mean age of
41 years (range: 20 67 yrs). 14 of these 27 patients
underwent subsequent surgical treatment with an average
follow-up period of 1.67 months (range: 7 day 9 months)
after the injections.
Injection Technique
All procedures were performed in a sterile manner, and
fluoroscopic guidance was used for the injections. The
patients were placed prone on a fluoroscopy table and the
C-arm was rotated to an ipsilateral oblique angle with
respect to the suspected nerve root (L4, 5 or S1) (Fig. 1).
Lidocaine (1%) was used for the cutaneous and needle
tract local anesthesia. After placing a 22 gauge spinal
needle at the appropriate level, epidurography with
contrast agent was performed to evaluate the anatomy of
the epidural space and the distribution of the injection fluid
for ensuring that the desired compartment was adequately
targeted. We used triamcinolone acetonide suspension 1 cc
(Triamcinolone
R 40 mg [Apothecon, Princeton, NJ]) as the
long-acting steroid and bupivacain hydrochloride 0.5 cc
(Marcaine
R 0.5% [Astra USA, Westborough, MA]) as the
long-acting local anesthetic. After the procedure, the
patient was observed in the short-stay unit for 0.5 1 hour
depending on his or her condition. Ten of 68 patients
underwent repeat injections; five patients were injected
twice, two patients were injected three times, two patients
were injected four times and one patient was injected five
times. The interval between the injections was three weeks
to six months. Although we usually waited 2 3 months
before administering repeat injections, the repeat injection
was performed in two patients only three weeks after the
previous injection. In those patients, we used the half
amount of the triamcinolon (20 mg) in the later injections.
For the patients who had underwent repeated injections,
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satisfaction score greater than two and a pain reduction
score greater than 50% at the last visit compared to the
score before the injection.
Analysis of MR Findings
The MR findings were assessed for the type, hydration,
location and size (volume) of the herniated disc, the grade
of nerve root compression and the associated findings of
spinal stenosis. The type of herniated disc was classified as
protrusion, extrusion and sequestration. It is important to
note that the interpretation of the extruded disc herniation
is partly subjective. Hydration of the herniated disc was
assessed on the MRI T2 sagittal and axial images, and this
was classified as high, moderate or low. The location of the
herniated disc was classified as central, left/right central,
subarticular or foraminal/extraforaminal according to the
recommendations of the combined task forces of the North
American Spine Society, the American Society of Spine
Radiology and the American Society of Neuroradiology
(17). The size of the herniated disc was determined by
calculating its volume from the axial and sagittal scans.
Measurement was performed on a PACS system with
drawing the disc and herniation. The grade of nerve root
compression was classified as 1 (abutment), 2 (displace-
ment) and 3 (entrapment) (Fig. 2). The findings of associ-
ated spinal stenosis (at the central, lateral recess or neural
foramen level) were also based on the MR images. Those
findings were compared between the responders (n = 41)
and the non-responders (n = 27) to the transforaminal ESI. 
Statistical Analysis
To determine the relationship between the MR findings
and the clinical outcome, the differences between the
responder and non-responder groups in terms of the
injection level, the type of heriation, the hydration, the
location of the herniated disc, the grade of nerve root
compression and the association with spinal stenosis were
analyzed using Chi-Square or Fisher’s exact tests. Student’s
T test was used for comparing the size of the herniated
discs, patient age and gender, and the pre-injection
symptom duration between the two groups. A logistic
Choi et al.
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Fig. 1. Transforaminal epidural steroid
injection. 
A. Left anterior oblique radiograph for the
right L5 transforaminal injection. The
triangle is formed by the iliac crest (IC), the
inferior margin of the right transverse
process (TP), and the right S1 superior
articular process (SAP). 
B. Left anterior oblique  radiograph for
needle positioning. The needle tip is inferior
and lateral to the right L5 pedicle (p =
pedicle). 
C. Epidurography shows the outline of the
right L5 nerve root sleeve (arrows). 
D. Epidurography for the left L4 transforam-
inal injection. Contrast is seen outlining the
left L4 nerve root sleeve (arrows). 
E. Epidurography for the right S1
transforaminal injection (arrows).
AB C
DEregression analysis was also used to determine the factors
contributing to a successful clinical outcome. 
RESULTS
The final analysis included 68 patients with an average
follow-up period of 3.6 months (range: 7 days 24
months). There were no serious side effects of the
injections. Transforaminal ESIs were given at the following
levels and all the procedures were done at a single level:
L4 in two patients, L5 in 36 patients and S1 in 30 patients. 
Forty one of 68 patients (60.3%) had successful
outcomes (the responders), and twenty seven patients
showed unsatisfactory results (the non-responders). The
pre-injection symptom duration of the responders ranged
from 3 days to 2.5 years, and that of the non-responders
was from 6 days to 2 years. There was no significant differ-
ence between the responders and non-responders in terms
of injection level, age, gender or the pre-injection symptom
duration (p > 0.05). Seven of 41 responders and three of
27 non-responders underwent repeat injections.
On the MR analysis, there was no significant difference
between the responders and non-responders in terms of
the type, hydration and size of the herniated disc, or an
association with spinal stenosis (p > 0.05) (Table 1).
However, the location of the herniated disc and the grade
of nerve root compression were different between the two
groups (p < 0.05) (Tables 2, 3). A centrally located
herniated disc was more common in the responder group
(Fig. 3), and an extraforaminal disc herniation was also
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Table 1. Comparison of MRI between Responders and Non-Responders (Fisher’s exact test, p > 0.05)
Type of the HIVD Hydration of the HIVD Association of 
Protrusion Extrusion Sequestration High Moderate  Low Spinal Stenosis
R (n = 41) 20 (49%) 20 (49%) 1 (2%)0 12 (29%) 19 (46%) 10 (24%) 5 (12%)
NR (n = 27) 10 (37%) 13 (48%) 4 (15%) 05 (19%) 12 (44%) 10 (37%) 6 (22%)
Note. Values represent the number of patients, HIVD = herniated intervertebral disc, R = responders, NR = non-responders.
Table 2. Comparison of the Location of HIVD between Responders and Non-Responders (Fisher’s exact test, p < 0.05)
Location of the HIVD
Central Left/right Central Subarticular Foraminal  Extraforaminal
R (n = 41) 11 (27%) 29 (71%) 0 (0%)0 0 (0%) 1 (2.4%) 
NR (n = 27) 1 (4%) 20 (74%) 6 (22%) 0 (0%) 0 (0%)0.
Note. Values represent the number of patients, HIVD = herniated intervertebral disc, R = responders, NR = non-responders. 
Fig. 2. Grade of nerve root compression. 
A. Grade I (abutment); the herniated disc abuts the nerve root, but the nerve root is in its normal position. 
B. Grade II (displacement); the herniated disc material displaces the nerve root, but the displaced nerve root can be seen by MRI. 
C. Grade III (entrapment); the nerve root is entrapped between the herniated disc and the lamina or facet. The entrapped nerve root is
hardly detected by MRI. 
ABCsuccessfully treated (Fig. 4). Treatment of six subarticularly
located herniated discs showed unsatisfactory results (Fig.
5). The grade of nerve root compression also correlated
with the clinical outcome (Fig. 6). Grade 2 or 3 nerve root
compression showed more unsatisfactory results than the
grade 1 nerve root compression (odds ratio: 7.43 and 25.9,
respectively).
DISCUSSION
Epidural steroid injection has been used as an adjunct in
the treatment of sciatica for a long time. Particularly, the
high efficacy of image-guided transforaminal injections
were explained by their presumed mechanisms of actions
Choi et al.
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Fig. 3. MRI of a 66-year-old man.
Central disc herniation and grade I
nerve root compression with a success-
ful result. Mid-line sagittal (A) and axial
(B) T2-weighted MR images show
central disc protrusion (arrows). The
disc was abutting both S1 nerve roots
(arrowheads). Because the distribution
of the patient’s pain was along the right
S1 dermatome and the electrodiagnostic
study showed right S1 radiculopathy, we
performed right S1 transforaminal ESI.
The follow-up assessment seven
months after injection showed a pain
reduction greater than 50% and a
patient satisfaction score of 2. 
AB
Fig. 4. MRI of a 56-year-old woman. Extraforaminal disc herniation with a successful result. She was suffering from severe posterior
thigh and lateral leg pain with tingling sensations. Surgery was planned for this patient as conservative management with oral and
intravenous medication had failed. 
A-C. The T1-weighted consecutive axial images. Extraforaminal disc herniation (arrow) is observed just above the level of the L5-S1
disc. Note that the disc is located at the extraforaminal course of the left L5 nerve (arrowheads). Left L5 transforaminal epidural steroid
injection resulted in remarkable improvement and it removed the need for surgery. Eight months after injection the symptoms had
disappeared and she was in a satisfactory condition.
ABC
Table 3. Comparison of the Grade of Nerve Root
Compression between Responders and Non-
Responders (Fisher’s exact test, p < 0.05)
Grade of Nerve Root Compression
123
R (n = 41) 13 (32%) 21 (51%) 07 (17%)
NR (n = 27) 1 (4%) 12 (44%) 14 (52%)
Note. Values represent the number of patients, HIVD = herniated 
intervertebral disc, R = responders, NR = non-responders.that include precise delivery of the steroid and anesthetic
solution (both of which have nociceptive properties), the
nerve membrane-stabilizing properties of both steroid and
anesthetic, the “wash out” effect of the solution which
decreases the levels of the regional inflammatory
mediators such as interleukin-1, tumor necrosis factor and
phospholipase A2, and the potent anti-inflammatory
properties of the steroid (18, 19). Transforaminal ESI also
decreases the risk of intravascular injection or dural
puncture compared with the traditional techniques that are
done without fluoroscopy (6). Nevertheless, a significant
number of patients continue to show symptoms after
transforaminal ESI, and then surgery is required after
several months. Therefore, it would be useful for both
patients and clinicians to know the likely outcome of non-
surgical treatments and the likelihood of future surgery. 
Several outcome studies of ESI treatment for lumbar
herniated discs have evaluated the clinical differences
between responders and non-responders (6 10). Lutz et
al. have reported that patients with pre-injection symptom
durations of less than 36 weeks were most likely to
respond to treatment (6). Viton et al. have found that the
decrease in pain was greater for the patients less than 50
years of age than for the older patients after transforaminal
ESI for lumbar radiculopathy (10). However, the clinical
data from these studies were variable and the studies were
not in accordance with each other (6 10). The results of
the present study indicated there was no significant differ-
ence between the responders and non-responders to
transforaminal ESI in terms of the injection level, age,
gender or pre-injection symptom duration (p > 0.05). In
our study, the follow-up period of the non-responders was
shorter than that of the responders. That was because most
of the non-responders underwent subsequent surgery for
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Fig. 5. MRI of a 49-year-old man.
Subarticular disc herniation with an
unsatisfactory result. 
A, B. The T2-weighted consecutive axial
images from the L5-S1 disc level. An
extruded disc herniation is noted in the
subarticular portion of the left L5-S1
(arrows). The nerve root is entrapped in
the left lateral recess of S1. Although left
S1 transforaminal epidural steroid
injection was performed, the symptoms
persisted. The patient underwent a
disectomy two months after injection. 
AB
Fig. 6. MRI of a 46-year-old woman.
Grade III nerve root compression with
an unsatisfactory result. The parame-
dian sagittal (A) and axial (B) T2-
weighted MR images show a left central
extruded disc herniation (arrows). The
margin of the herniated disc has
moderate signal intensity. The left S1
nerve root is not visible due to the
herniated disc, as compared to the right
S1 nerve root (arrowhead). Left S1
transforaminal epidural steroid injection
was performed, but the symptoms
persisted. The patient underwent
surgery 1.5 months after injection.
ABpain relief within a short follow-up interval. 
Although abnormal imaging findings do not always
correlate with the patient’s symptoms (20, 21), many
studies have investigated the prognostic value of MRI, and
they have used MRI to evaluate the morphology changes
caused by lumbar disc herniation (11 16). Using MRI,
Komori et al. have reported that large sequestered or
extruded disc herniations frequently decreased in size after
conservative treatment (16). In a study examining the
prognostic value of postcontrast MR enhancement in
lumbar discs, Gallucci et al. have found that the high signal
intensity of the disc fragment on the T2-weighted images
were related to a reduction of the disc fragment itself (13).
In the present study, there was no significant difference
between the responders and non-responders in terms of
the type, hydration or size of the herniated disc. The likely
explanation for the different result is that the studies of
Komori et al. and Gallucci et al. included the patients
undergoing only conservative treatment without ESI.
Therefore, although their findings indicated that conserva-
tive treatment resulted in a size reduction of the large,
migrating herniated discs with high signal intensity and the
patients showed good clinical outcome, these data could
not predict the response of such disc herniations to ESI.
Besides, Buttermann reported that ESI does not ultimately
alter the regression of the herniated nucleus pulposus, and
that patients with less hydrated discs may have more
prolonged symptoms, although many improve with ESI
(15). 
Many studies have reported a poor response to ESI in
patients with disc herniation combined with spinal stenosis
or spondylolisthesis (7, 8, 22). Spinal stenosis and spondy-
lolisthesis with a prolonged symptom duration can result in
irreversible changes that are related to chronic inflamma-
tion, and this may render the nerve root refractory to
management by the local application of steroid (7).
However, spinal stenosis did not affect the clinical outcome
to ESI in the current study because we excluded as such
patients from our study.
The present study showed that the location and grade of
nerve root compression resulted in significantly different
responses to transforaminal ESI. The one case of
extraforaminal disc herniation showed a successful result.
It was similar with a case reported by Komori et al. (16). In
contrast, all the subarticular disc herniations and the disc
herniations that severely compressed the nerve root
showed unsatisfactory results. It can be assumed that the
subarticular location affected the nerve root about the
same as a lateral recess stenosis, and severe nerve root
compression or entrapment could make the nerve root to
be unresponsive to ESI.
It is pertinent to note the limitations of the present study.
First, it was not a double-blind controlled study, which
may have affected the clinical outcome measurements
following transforaminal ESI. Second, the clinical follow-
up interval and repeated injection criteria were not
uniform since this study was a retrospective trial.
Therefore, the evaluation of the transforaminal ESI result
according to the time interval was limited. A prospective
study with a regular protocol is needed for such an evalua-
tion. Third, the follow-up interval was relatively short,
with the average follow-up period being 4.2 months in the
responder group. However, the interval between injection
and surgery was only 1.67 months (range: 7 days to 9
months) for the non-responders, suggesting that the short-
term outcome of ESI is important for the future manage-
ment of patients with disc herniation. Finally, although
there have been reports on the prognostic value of
contrast-enhanced MRI (13, 14) and also reports on the
morphological changes observed on follow-up MRI after
conservative management of lumbar disc herniation (11,
15), we can not evaluate these since contrast enhancement
was not routinely performed, and the follow-up MRIs were
obtained in only a few cases.
In conclusion, although the present study has its limita-
tions, the results suggest that MRI could play an important
role in predicting the clinical outcome of non-surgical
transforaminal ESI treatment for the patients suffering with
lumbar disc herniation. 
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